Phase III study of adjuvant vaccination with bec/bacile calmetteguerin in responding patients with limited-disease small-cell lung cancer (European Organisation for research and treatment of cancer 08971-08971B; Silva study)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F05%3A00000023" target="_blank" >RIV/00064211:_____/05:00000023 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Phase III study of adjuvant vaccination with bec/bacile calmetteguerin in responding patients with limited-disease small-cell lung cancer (European Organisation for research and treatment of cancer 08971-08971B; Silva study)
Original language description
Phase III study of adjuvant vaccination with bec/bacile calmetteguerin in responding patients with limited-disease small-cell lung cancer
Czech name
Studie III. fáze adjuvantní vakcinace s Bec2/Bacile Calmete-Guerin u pacinetů s limitovaným malobuněčným karcinomem plic
Czech description
Studie III. Fáze adjuvantní vakcinace s Bec2/Bacile Calmette-Guerin u pacientů s limitovaným malobuněčným karcinomem plic
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Clinical Oncology
ISSN
0732-183X
e-ISSN
—
Volume of the periodical
23
Issue of the periodical within the volume
28
Country of publishing house
US - UNITED STATES
Number of pages
11
Pages from-to
6854-6864
UT code for WoS article
—
EID of the result in the Scopus database
—